[Theory of antithrombogenic surfaces. II].
D000200:Action Potentials; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology; D001807:Blood Vessel Prosthesis / Q000009:adverse effects; D005549:Foreign-Body Reaction; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D007202:Indicators and Reagents; D009757:Nylons / Q000009:adverse effects; D010973:Platelet Adhesiveness / Q000187:drug effects; D011093:Polyethylene Terephthalates / Q000009:adverse effects; D011138:Polytetrafluoroethylene / Q000009:adverse effects; D011183:Postoperative Complications / Q000517:prevention & control*; D011487:Protein Conformation / Q000187:drug effects; D013499:Surface Properties; D013501:Surface-Active Agents / Q000009:adverse effects; D013927:Thrombosis / Q000517:prevention & control*
D007202:Indicators and Reagents; D009757:Nylons; D011093:Polyethylene Terephthalates; D013501:Surface-Active Agents; D011138:Polytetrafluoroethylene; D006493:Heparin
Zur Theorie der antithrombogenen Oberflächen. II